These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38971512)

  • 1. Irinotecan-loaded magnetite-silica core-shell systems for colorectal cancer treatment.
    Chircov C; Petcu MC; Vasile BS; Purcăreanu B; Nicoară AI; Oprea OC; Popescu RC
    Int J Pharm; 2024 Aug; 661():124420. PubMed ID: 38971512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
    Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostic magnetite cluster@silica@albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents.
    Maboudi SA; Shojaosadati SA; Aliakbari F; Arpanaei A
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1485-1492. PubMed ID: 30889683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan, magnetite, silicon dioxide, and graphene oxide nanocomposites: Synthesis, characterization, efficiency as cisplatin drug delivery, and DFT calculations.
    Abdel-Bary AS; Tolan DA; Nassar MY; Taketsugu T; El-Nahas AM
    Int J Biol Macromol; 2020 Jul; 154():621-633. PubMed ID: 32179117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
    Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro testing of thermoresponsive polymer-grafted core-shell magnetic mesoporous silica nanoparticles for efficient controlled and targeted drug delivery.
    Peralta ME; Jadhav SA; Magnacca G; Scalarone D; Mártire DO; Parolo ME; Carlos L
    J Colloid Interface Sci; 2019 May; 544():198-205. PubMed ID: 30844568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release.
    Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K
    Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
    Nasri N; Saharkhiz S; Dini G; Yousefnia S
    Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile Layer-by-Layer Self-Assembly toward Enantiomeric Poly(lactide) Stereocomplex Coated Magnetite Nanocarrier for Highly Tunable Drug Deliveries.
    Li Z; Yuan D; Jin G; Tan BH; He C
    ACS Appl Mater Interfaces; 2016 Jan; 8(3):1842-53. PubMed ID: 26717323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core-shell Fe3O4@SiO2 nanoparticles synthesized with well-dispersed hydrophilic Fe3O4 seeds.
    Hui C; Shen C; Tian J; Bao L; Ding H; Li C; Tian Y; Shi X; Gao HJ
    Nanoscale; 2011 Feb; 3(2):701-5. PubMed ID: 21103488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.
    Abbasi Aval N; Pirayesh Islamian J; Hatamian M; Arabfirouzjaei M; Javadpour J; Rashidi MR
    Int J Pharm; 2016 Jul; 509(1-2):159-167. PubMed ID: 27234695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
    Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer.
    Siminzar P; Omidi Y; Golchin A; Aghanejad A; Barar J
    J Drug Target; 2020 Jan; 28(1):92-101. PubMed ID: 31062625
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kumar H; Pani B; Kumar J; Kumar P
    Curr Pharm Biotechnol; 2023; 24(10):1297-1306. PubMed ID: 37254276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen-coated superparamagnetic iron oxide nanoparticles as a sustainable catalyst for spirooxindole synthesis.
    Azarnier SG; Esmkhani M; Dolatkhah Z; Javanshir S
    Sci Rep; 2022 Apr; 12(1):6104. PubMed ID: 35414646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication and spectroscopic studies of folic acid-conjugated Fe3O4@Au core-shell for targeted drug delivery application.
    Karamipour Sh; Sadjadi MS; Farhadyar N
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Sep; 148():146-55. PubMed ID: 25879984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
    Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
    Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
    Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
    An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.